Risk of malignancy index in preoperative evaluation of pelvic masses

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 7, 2011, Pages 1727-1730

  Ashrafgangooei, Tahereh ^a   Rezaeezadeh, Mahdieh ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ovarian cancer; Pelvic masses; Preoperative evaluation; Risk of malignancy index

Indexed keywords

CA 125 ANTIGEN; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN;

ADNEXA DISEASE; ADULT; ARTICLE; BLOOD; ECHOGRAPHY; EVALUATION; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; MENOPAUSE; MIDDLE AGED; OVARY TUMOR; PELVIS TUMOR; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADNEXAL DISEASES; ADULT; CA-125 ANTIGEN; DIAGNOSTIC TECHNIQUES, OBSTETRICAL AND GYNECOLOGICAL; FEMALE; HUMANS; MEMBRANE PROTEINS; MENOPAUSE; MIDDLE AGED; OVARIAN NEOPLASMS; PELVIC NEOPLASMS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84864328976     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. American Cancer Society. Cancer facts and figures 2004. Available from: http://209.135.47.118/downloads/STT/CAFF_finalPWSecured.pdf. Access: 20 Jul 2010
2. American Cancer Society. Cancer Facts & Figures 2010. Available from: http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113.pdf.Access: 20 Jul 2010.
3. Andersen ES, Knudsen A, Rix P, et al (2003). Risk of malignancy index in the preoperative evaluation of patients with adnexal masses. Gynecol Oncol, 90, 109-112.
4. Bailey J, Tailor A, Naik R, et al (2006). A risk of malignancy index for referral of ovarian cancer cases to tertiary center: does it identify the correct cases. Int J Gynecol Cancer, 166, 30-34.
5. Bell R, Petticrew M, Sheldon T (1998). The performance of screening tests for ovarian cancer: results of a systematic review. Br J Obstet Gynaecol, 105, 1136-1147.
6. Benedet JL, Hacker NF, Ngan HYS (2000). Staging classifications and clinical practice guidelines of gynaecologic cancers. Int J Gynecol Obstet, 70, 207-312.
7. Davies AP, Jacobs I, Woolas R, Fish A, Oram D (1993). The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. Br J Obstet Gynaecol, 100, 927-931.
8. Earle CC, Schrag D, Neville BA et al. (2006). Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst, 98, 172-180.
9. Enakpene CA, Omigbodun AO, Goecke TW, et al (2009). Preoperative evaluation and triage of women with suspicious adnexal masses using risk of malignancy index. J Obstet Gynaecol Res, 35, 131-8.
10. Engeland A, Haldorsen T, Tretli S, et al (1995). Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010. APMIS, 49, 1-161.
11. Engelen MJ, Kos HE, Willemse PH, et al (2006). Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer, 106, 589-98.
12. Greenlee RT, Hill-Harmon MB, Murray T, et al (2001). Cancer statistics, 2001. CA Cancer J Clin, 51, 15-36.
13. Grimes DA, Hughes JM (1989). Use of multiphasic oral contraceptives and hospitalizations of women with functional ovarian cysts in the United States. Obstet Gynecol, 73,1037-1039.
14. Guidozzi F (1996). Screening for ovarian cancer. Obstet Gynecol Surv, 51,696-701.
15. Landis SH, Murray T, Bolden S, et al (1998). Cancer Statistics, 1998. CA Cancer J Clin, 48, 6-29.
16. Jacobs I, Oram D, Fairbanks J, et al (1990). A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol, 97, 922-9.
17. Manjunath AP, Pratapkumar AP, Sujatha K, et al (2001).Comparison of three risk-of-malignancy indices in evaluation of pelvic masses. Gynecol Oncol, 81, 225-9.
18. Obeidat BR, Amarin A, Latimer JA, et al (2004). Risk of malignancy index in the preoperative evaluation of pelvic masses. Int J Gynecol, 85, 255-8.
19. Tingulstad S, Hagen B, Skjeldestad FE, et al (1999). The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol, 93, 448-52.
20. Tingulstad S, Hagen B, Skjeldestad FE, et al (1996). Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol, 103, 826-31.
21. Vernooij F, Heintz AP, Coebergh JW, et al (2009). Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands. Gynecol Oncol, 112, 455-61.
22. Yuen PM, Yu KM, Yip SK, et al (1997). A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses. Am J Obstet Gynecol, 177, 109-14.
23. Zalel Y, Tepper R, Altaras M, et al (1996). Transvaginal sonographic measurements of postmenopausal ovarian volumes as a possible detection of ovarian neoplasia. Acta Obstet Gynecol Scand, 75, 668-71.